Breast cancer:assessing axillary lymph node involvement. Can PET provide a comprehensive and less invasive alternative to dissection? In; Clinical application and economic implications of PET in the assessment of axillary lymph node involvement in breast cancer: a retrospective study. Abstract from the 1994 ICP Meeting, ICP Breast Cancer Task Force 2–8, 1994.
2.
CrippaF., BombardieriE.: La tomografia con emissione di positroni (PET): caratteristiche e possibili applicazioni nell'oncologia clinica. Radiol. Med., 92: 453–460, 1996.
3.
FedeleM.: La ristrutturazione dell'industria farmaceutica italiana: spunti propositivi e quadro delle opzioni. Farmaci, 26: 26–29, 1996.
4.
GambhirS.S., HohC.K., PhelpsM.E., MadarI., MaddahiJ.: Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J. Nucl. Med., 37: 1428–1436, 1996.
5.
RigoP., PaulusP., KaschtenB.J., HustinxR., BuryT., JerusalemG., BenoitT., Foidart-WillemsJ.: Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur. J. Nucl. Med., 23: 1641–1674, 1996.
6.
ValkP.F., PoundsT.R., TesarR.D., HopkinsD.M., HasermanM.K.: Cost-effectiveness of PET imaging in clinical oncology. Nucl. Med. & Biol., 25: 737–743, 1996.
